BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38331558)

  • 1. Navigating into a stormy sea: liquid biopsy enters peri-operative management in early-stage non-small cell lung cancer.
    Rolfo C; Russo A
    Ann Oncol; 2024 Feb; 35(2):147-149. PubMed ID: 38331558
    [No Abstract]   [Full Text] [Related]  

  • 2. How to Select Patients With Clinically Early-Stage Non-Small Cell Lung Cancer for Segmentectomy?
    Deng HY; Tang X; Zhou Q
    Chest; 2021 Jan; 159(1):444-445. PubMed ID: 33422216
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy?
    Mimae T; Saji H; Okada M
    Ann Surg Oncol; 2021 Nov; 28(12):7228-7229. PubMed ID: 33759046
    [No Abstract]   [Full Text] [Related]  

  • 4. Liquid biopsies to optimize therapeutic efficacy in unresponsive lung cancer patients.
    Santarpia M; Funel N; Ali A; Giovannetti E
    Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):761-763. PubMed ID: 29933706
    [No Abstract]   [Full Text] [Related]  

  • 5. Segmentectomy is the Surgical Procedure of Choice for Peripheral Early-Stage Non-small Cell Lung Cancer (Most Likely!).
    Brunelli A
    Ann Surg Oncol; 2023 Aug; 30(8):4553-4555. PubMed ID: 37138169
    [No Abstract]   [Full Text] [Related]  

  • 6. Standards of practice: guidelines for thermal ablation of primary and secondary lung tumors.
    Pereira PL; Masala S;
    Cardiovasc Intervent Radiol; 2012 Apr; 35(2):247-54. PubMed ID: 22271076
    [No Abstract]   [Full Text] [Related]  

  • 7. Synchronous Bilateral Lung Cancer With Discordant Histology.
    Copur MS; Lackner R; Wedel W; Lintel N; Lintel MS; Gnatra K
    Oncology (Williston Park); 2020 Feb; 34(2):55-60. PubMed ID: 32645196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic Body Radiation Therapy vs Surgery for Early-Stage Non-Small Cell Lung Cancer: Does the Dealer Influence the Choice?
    Jafferji M; Hamstra DA; Groth SS
    Ann Thorac Surg; 2023 Feb; 115(2):354-355. PubMed ID: 36070808
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of Discrepant Driver Mutations in a Patient with Two Synchronous Primary Non-Small Cell Lung Cancers (NSCLCs) with Liquid Biopsy.
    Lakis S; Heukamp LC; Griesinger F
    J Thorac Oncol; 2017 Nov; 12(11):e186-e188. PubMed ID: 29074212
    [No Abstract]   [Full Text] [Related]  

  • 10. Triple synchronous primary lung cancer.
    Zardo P; Krüer T; Schiffmann S; Freermann S; Fischer S
    Asian Cardiovasc Thorac Ann; 2014 Sep; 22(7):865-8. PubMed ID: 24887854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-small-cell lung carcinoma].
    Pabst S; Stier S; Vetter H; Grohé Ch
    Praxis (Bern 1994); 2004 Dec; 93(50):2085-92. PubMed ID: 15646675
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgical staging for non-small cell lung cancer.
    Gamliel Z
    Surg Oncol Clin N Am; 2011 Oct; 20(4):691-700. PubMed ID: 21986266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in Surgical Treatment of Early Stage Non-small Cell Lung Cancer].
    Hu J; Bao F
    Zhongguo Fei Ai Za Zhi; 2016 Jun; 19(6):399-402. PubMed ID: 27335305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress of liquid biopsy technique and clinical application in lung cancer].
    Wang NF; Yang Y; Chen SF
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Nov; 41(11):881-883. PubMed ID: 30423633
    [No Abstract]   [Full Text] [Related]  

  • 15. Staging and the surgical management of lung cancer.
    Park BJ; Louie O; Altorki N
    Radiol Clin North Am; 2000 May; 38(3):545-61, ix. PubMed ID: 10855261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving role of liquid biopsy in lung cancer.
    Malapelle U; Pisapia P; Pepe F; Russo G; Buono M; Russo A; Gomez J; Khorshid O; Mack PC; Rolfo C; Troncone G
    Lung Cancer; 2022 Oct; 172():53-64. PubMed ID: 35998482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the 7th TNM staging lung cancer in surgery.
    Bamousa A; AlKattan K
    J Infect Public Health; 2012 Dec; 5 Suppl 1():S41-4. PubMed ID: 23244187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving use of liquid biopsy in non-small-cell-lung cancer patients.
    Indraccolo S
    Int J Biol Markers; 2020 Feb; 35(1_suppl):23-25. PubMed ID: 32079459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC.
    Rolfo C; Mack PC; Scagliotti GV; Baas P; Barlesi F; Bivona TG; Herbst RS; Mok TS; Peled N; Pirker R; Raez LE; Reck M; Riess JW; Sequist LV; Shepherd FA; Sholl LM; Tan DSW; Wakelee HA; Wistuba II; Wynes MW; Carbone DP; Hirsch FR; Gandara DR
    J Thorac Oncol; 2018 Sep; 13(9):1248-1268. PubMed ID: 29885479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgeon plays probably a pivotal role in the management of bronchial carcinoma].
    Kilani T
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S21-10S22. PubMed ID: 17127956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.